Inventor
JIN ZENG
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07DHeterocyclic compounds18%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07KPeptides9%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes9%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data9%
PatentTitleYear
12,437,880Consistency evaluation method for traditional extraction process and modern extraction process of traditional Chinese medicine compound preparation202512,421,254KRAS modulators and uses thereof202512,145,947Pyrimidine based modulators and uses thereof202411,459,361Sericin protein particle with oxidative stress property, method for preparing the same and use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to HANGZHOU SINGCLEAN MED PROD CO LTD (1)· patent assignee history
2022–2025Based in CN· patent location history
2024–2025Patents assigned to QUANTA THERAPEUTICS INC (2)· patent assignee history
2024–2025Based in US· patent location history
2025Patents assigned to SICHUAN ACAD CHINESE MEDICINE SCIENCES (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| QUANTA THERAPEUTICS INC | 2 | 2024–2025 |
| HANGZHOU SINGCLEAN MED PROD CO LTD | 1 | 2022 |
| SICHUAN ACAD CHINESE MEDICINE SCIENCES | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 2 | 2022–2025 |
| US | 2 | 2024–2025 |